CN117715658A - 抑制ras的方法 - Google Patents

抑制ras的方法 Download PDF

Info

Publication number
CN117715658A
CN117715658A CN202280050079.1A CN202280050079A CN117715658A CN 117715658 A CN117715658 A CN 117715658A CN 202280050079 A CN202280050079 A CN 202280050079A CN 117715658 A CN117715658 A CN 117715658A
Authority
CN
China
Prior art keywords
optionally substituted
membered
alkyl
hydrogen
ras
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280050079.1A
Other languages
English (en)
Chinese (zh)
Inventor
K·西蒙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ruixin Pharmaceutical Co
Original Assignee
Ruixin Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruixin Pharmaceutical Co filed Critical Ruixin Pharmaceutical Co
Priority to CN202410561373.XA priority Critical patent/CN118557730A/zh
Publication of CN117715658A publication Critical patent/CN117715658A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN202280050079.1A 2021-05-25 2022-05-25 抑制ras的方法 Pending CN117715658A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410561373.XA CN118557730A (zh) 2021-05-25 2022-05-25 抑制ras的方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192837P 2021-05-25 2021-05-25
US63/192837 2021-05-25
PCT/US2022/030823 WO2022251292A1 (en) 2021-05-25 2022-05-25 Methods for inhibiting ras

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202410561373.XA Division CN118557730A (zh) 2021-05-25 2022-05-25 抑制ras的方法

Publications (1)

Publication Number Publication Date
CN117715658A true CN117715658A (zh) 2024-03-15

Family

ID=82115695

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202280050079.1A Pending CN117715658A (zh) 2021-05-25 2022-05-25 抑制ras的方法
CN202410561373.XA Pending CN118557730A (zh) 2021-05-25 2022-05-25 抑制ras的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202410561373.XA Pending CN118557730A (zh) 2021-05-25 2022-05-25 抑制ras的方法

Country Status (11)

Country Link
US (1) US20240277796A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346898A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024521774A (cg-RX-API-DMAC7.html)
KR (1) KR20240026526A (cg-RX-API-DMAC7.html)
CN (2) CN117715658A (cg-RX-API-DMAC7.html)
AU (1) AU2022281343A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219533A1 (cg-RX-API-DMAC7.html)
IL (1) IL308771A (cg-RX-API-DMAC7.html)
MX (1) MX2023013912A (cg-RX-API-DMAC7.html)
TW (1) TW202313631A (cg-RX-API-DMAC7.html)
WO (1) WO2022251292A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026124659A1 (zh) * 2024-12-13 2026-06-18 苏州泽璟生物制药股份有限公司 二羰基类抑制剂及其制备方法和应用

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy
IL308195A (en) 2021-05-05 2024-01-01 Revolution Medicines Inc RAS inhibitors for cancer treatment
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
EP4463231A1 (en) * 2022-01-10 2024-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2023232776A1 (en) * 2022-06-01 2023-12-07 F. Hoffmann-La Roche Ag Haloindole macrocyclic compounds for the treatment of cancer
EP4596552A1 (en) 2022-09-29 2025-08-06 Guangzhou Joyo Pharmatech Co., Ltd Macrocyclic derivative and use thereof
PE20252395A1 (es) 2023-02-14 2025-10-10 Hoffmann La Roche Compuestos triciclicos para el tratamiento de cancer
CN121487738A (zh) * 2023-03-30 2026-02-06 锐新医药公司 诱导ras gtp水解的组合物和其用途
TW202446387A (zh) * 2023-04-06 2024-12-01 瑞士商赫孚孟拉羅股份公司 用於治療癌症之三環化合物
KR20260019479A (ko) 2023-05-04 2026-02-10 레볼루션 메디슨즈, 인크. Ras 관련 질환 또는 장애를 위한 병용 요법
WO2025006967A1 (en) 2023-06-30 2025-01-02 Bristol-Myers Squibb Company Kras inhibitors
CN121693329A (zh) * 2023-07-14 2026-03-17 锐新医药公司 治疗ras相关疾病或病症的方法
WO2025162395A1 (zh) * 2024-02-01 2025-08-07 山东先声生物制药有限公司 吲哚衍生物作为ras抑制剂及其应用
CN119431325A (zh) * 2024-10-31 2025-02-14 诚达药业股份有限公司 一种3-(1h-吡唑-1-基)氮杂环丁烷类化合物及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL317393A (en) 2018-12-21 2025-02-01 Revolution Medicines Inc Compounds that participate in covalent bonds and their uses
DE102019122206B4 (de) 2019-08-19 2021-07-08 Webasto SE Dachmodul zur Bildung eines Fahrzeugdachs mit Umfeldsensor
CN121471132A (zh) 2019-11-04 2026-02-06 锐新医药公司 Ras抑制剂
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026124659A1 (zh) * 2024-12-13 2026-06-18 苏州泽璟生物制药股份有限公司 二羰基类抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
TW202313631A (zh) 2023-04-01
US20240277796A1 (en) 2024-08-22
CN118557730A (zh) 2024-08-30
AU2022281343A1 (en) 2023-11-30
MX2023013912A (es) 2024-02-12
IL308771A (en) 2024-01-01
JP2024521774A (ja) 2024-06-04
WO2022251292A1 (en) 2022-12-01
CA3219533A1 (en) 2022-12-01
EP4346898A1 (en) 2024-04-10
KR20240026526A (ko) 2024-02-28

Similar Documents

Publication Publication Date Title
AU2022360536B2 (en) Ras inhibitors
EP4054719B1 (en) Ras inhibitors
KR20240004960A (ko) Ras 억제제
CN118922423A (zh) Ras抑制剂
CN118557730A (zh) 抑制ras的方法
CN117616031A (zh) 用于治疗癌症的ras抑制剂
KR20260005904A (ko) 매크로사이클릭 ras 억제제
CN116457358A (zh) 作为ras抑制剂以治疗癌症的吲哚衍生物
JP2025037925A (ja) 協同的結合に関与する化合物及びその使用
EP4720072A2 (en) Ras inhibitors
CN121263418A (zh) 大环ras抑制剂
CN115873020A (zh) Ras抑制剂
CN115873067A (zh) Ras抑制剂
WO2025171296A1 (en) Ras inhibitors

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination